Fragile X cortex is characterized by decreased parvalbumin-expressing interneurons
Cerebral Cortex · 2024
DOI: 10.1093/cercor/bhae103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cerebral Cortex, 2024. Verfasst von Pablo Juarez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, UC Davis School of Medicine; Institute for Pediatric Regenerative Medicine and Shriners Hospitals fo…. Hauptthemen laut MEDLINE: Fragile X Syndrome, Autism Spectrum Disorder. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institute of Mental Health, Shriners Hospitals.
Abstract (Originalsprache)
Fragile X syndrome is a genetic neurodevelopmental disorder caused by a mutation of the fragile X messenger ribonucleoprotein 1 (FMR1) gene in the X chromosome. Many fragile X syndrome cases present with autism spectrum disorder and fragile X syndrome cases account for up to 5% of all autism spectrum disorder cases. The cellular composition of the fragile X syndrome cortex is not well known. We evaluated alterations in the number of Calbindin, Calretinin, and Parvalbumin expressing interneurons across 5 different cortical areas, medial prefrontal cortex (BA46), primary somatosensory cortex (BA3), primary motor cortex (BA4), superior temporal cortex (BA22), and anterior cingulate cortex (BA24) of fragile X syndrome and neurotypical brains. Compared with neurotypical cases, fragile X syndrome brains displayed a significant reduction in the number of PV+ interneurons in all areas and of CR+ interneurons in BA22 and BA3. The number of CB+ interneurons did not differ. These findings are the first to demonstrate that fragile X syndrome brains are characterized by cortical wide PV+ interneuron deficits across multiple cortical areas. These add to the idea that deficits in PV+ interneurons could disrupt the cortical balance and promote clinical deficits in fragile X syndrome patients and help to develop novel therapies for neurodevelopmental disorders like fragile X syndrome and autism spectrum disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, UC Davis School of Medicine; Institute for Pediatric Regenerative Medicine and Shriners Hospitals for Children of Northern California Sacramento, CA 95817, United States.
- MIND Institute, University of California, Davis, Sacramento, CA 95817, United States.
Förderung
- NIMH NIH HHS
- National Institute of Mental Health
- Shriners Hospitals
Zitieren
APA
Juarez, P., Salcedo-Arellano, M. J., Dufour, B., & Martinez-Cerdeño, V. (2024). Fragile X cortex is characterized by decreased parvalbumin-expressing interneurons. Cerebral Cortex. https://doi.org/10.1093/cercor/bhae103
Vancouver
Juarez P, Salcedo-Arellano MJ, Dufour B, Martinez-Cerdeño V. Fragile X cortex is characterized by decreased parvalbumin-expressing interneurons. Cerebral Cortex. 2024. doi:10.1093/cercor/bhae103
BibTeX
@article{Juarez2024,
author = {Juarez, Pablo and Salcedo-Arellano, Maria Jimena and Dufour, Brett and Martinez-Cerdeño, Veronica},
title = {Fragile X cortex is characterized by decreased parvalbumin-expressing interneurons},
journal = {Cerebral Cortex},
year = {2024},
doi = {10.1093/cercor/bhae103}
}
EUVIMED